Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: A single dose, 4 weeks, double-blind, randomized, placebo controlled trial

Neurourology and Urodynamics

Volumn 26, Issue 6, 2007, Pages 773-778

  Rios, Luis Augusto Seabra ^a,b,c   Panhoca, Renato ^b   Mattos Jr , Demerval ^b   Srugi, Miguel ^a   Bruschini, Homero ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Bladder; Capsaicin; Neurogenic bladder; Resiniferatoxin; Urinary incontinence

Indexed keywords

PLACEBO; RESINIFERATOXIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETRUSOR MUSCLE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSURIA; FEMALE; HEMATURIA; HUMAN; IDIOPATHIC DISEASE; OVERACTIVE BLADDER; PAIN; PARALLEL DESIGN; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME; URGE INCONTINENCE; URODYNAMICS;

ADMINISTRATION, INTRAVESICAL; DITERPENES; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; HUMANS; NEUROTOXINS; PLACEBOS; QUALITY OF LIFE; SOCIAL BEHAVIOR; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, STRESS; URINATION;

EID: 35148828276     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20300     Document Type: Article

References (21)

1. Milson I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001;87:760-6.
2. Brown JS, Vittinghoff E, Wyman JF, et al. Urinary incontinence: Does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc 2000;48:721-5.
3. de Groat WC. Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Paraplegia 1995;33:493-498.
4. Chancellor MB, de Groat W. Intravesical capsaicin and resiniferatoxin therapy: Spicing up the ways to treat the overactive bladder. J Urol 1999; 162:3-11.
5. Silva C, Ribeiro MJ, Cruz F. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 2002;168:575-9.
6. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: A heat activated ion channel in the pain pathway. Nature 1997;389:816-24.
7. Maggi CA, Barbanti G, Santicioli P, et al. Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol 1989;142:150-4.
8. Fowler CJ, Jewkes D, McDonald WI, et al. Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 1992;339:1239-41.
9. Cruz F, Guimaräes M, Silva C, et al. Suppression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet 1997;350:640-1.
10. de Ridder D, Chhandiramani V, Dasgupta P, et al. Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: A dual center study with long-term follow-up. J Urol 1997;158:2087-92.
11. de Seze M, Wiart L, Joseph PA, et al. Capsaicin and neurogenic detrusor hyperreflexia: A double blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 1998;17:513-6.
12. Cruz F, Guimarães M, Silva C, et al. Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol 1997;157:585-9.
13. Lazzeri M, Beneforti P, Turini D. Urodynamic effects of intravesical resiniferatoxin in humans: Preliminary results in stable and unstable detrusor. J Urol 1997;158:2093-6.
14. Chai TC, Gray ML, Steers W. The incidence of a positive ice water test in bladder outlet obstructed patients: Evidence for bladder neural plasticity. J Urol 1998;160:34-6.
15. Yokoyama O, Komatsu K, Yotsuyanagi S, et al. Diagnostic value of intravesical lidocaine for overactive bladder. J Urol 2000;164:340-3.
16. Kuo H-C. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. J Urol 2003;170:835-9.
17. Fowler CJ, Beck RO, Gerrard S, et al. Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 1994;57:169-73.
18. Lazzeri M, Beneforti G, Benaim G, et al. Intravesical capsaicin for treatment of severe bladder pain: A randomized placebo controlled study. J Urol 1996; 156:947-52.
19. Craft RM, Cohen SM, Porreca F. Long-lasting desensitization of bladder afferents following intravesical resiniferatoxin and capsaicin in the rat. Pain 1995;61:317-21.
20. Ost D, Van der Aa F, de Ridder D. Intravesical ethanol 10% in saline is not an inert vehicle. Neurourol Urodyn 2003;22:353-5.
21. Lazzeri M, Beneforti P, Spinelli M, et al. Intravesical resiniferatoxin for the treatment of hypersensitive disorder: A randomized placebo controlled study. J Urol 2000;164:676-9.